ATE526585T1 - Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon - Google Patents

Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon

Info

Publication number
ATE526585T1
ATE526585T1 AT06707378T AT06707378T ATE526585T1 AT E526585 T1 ATE526585 T1 AT E526585T1 AT 06707378 T AT06707378 T AT 06707378T AT 06707378 T AT06707378 T AT 06707378T AT E526585 T1 ATE526585 T1 AT E526585T1
Authority
AT
Austria
Prior art keywords
rcc356
coupled receptor
natural ligand
protein
isovaleric acid
Prior art date
Application number
AT06707378T
Other languages
English (en)
Inventor
Frederic Sallman
Alex Veithen
Magali Philippeau
Original Assignee
Chemcom Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemcom Sa filed Critical Chemcom Sa
Application granted granted Critical
Publication of ATE526585T1 publication Critical patent/ATE526585T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06707378T 2005-03-03 2006-03-02 Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon ATE526585T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05447046 2005-03-03
PCT/EP2006/001904 WO2006094704A2 (en) 2005-03-03 2006-03-02 Natural ligand of g protein coupled receptor rcc356 and uses thereof

Publications (1)

Publication Number Publication Date
ATE526585T1 true ATE526585T1 (de) 2011-10-15

Family

ID=35344663

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06707378T ATE526585T1 (de) 2005-03-03 2006-03-02 Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon

Country Status (9)

Country Link
US (1) US8008023B2 (de)
EP (1) EP1864131B1 (de)
JP (1) JP5307404B2 (de)
AT (1) ATE526585T1 (de)
AU (1) AU2006222265B2 (de)
CA (1) CA2597255C (de)
DK (1) DK1864131T3 (de)
ES (1) ES2373913T3 (de)
WO (1) WO2006094704A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1969374A4 (de) * 2006-01-04 2010-04-14 Univ Stanford Selbstbeleuchtende quantenpunktsysteme und anwendungsverfahren dafür
JP4980418B2 (ja) * 2007-03-19 2012-07-18 株式会社リバース・プロテオミクス研究所 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法
GB201020133D0 (en) * 2010-11-26 2011-01-12 Royal Holloway & Bedford New College Therapeutic use of compounds
US8637259B1 (en) * 2011-02-09 2014-01-28 Chemcom S.A. Methods of identifying modulators of olfactory receptors involved in the perception of sweat carboxylic acids
WO2013034666A2 (en) * 2011-09-08 2013-03-14 Chemcom S.A. Novel pheromonal receptor of spodoptera littoralis (lepidoptera, noctuidae) and identification of natural ligand of said receptor and uses thereof
JP5948139B2 (ja) * 2012-05-11 2016-07-06 ヒノキ新薬株式会社 サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤
JP6325088B2 (ja) 2013-05-31 2018-05-16 シェンコム・エス．エー．Ｃｈｅｍｃｏｍ Ｓ．Ａ． 汗カルボン酸の知覚に関与する嗅覚受容体およびその使用
WO2016123133A1 (en) * 2015-01-26 2016-08-04 The Johns Hopkins University Surface plasmon resonance approach to monitor protein-ligand interactions
JP6122181B2 (ja) 2015-06-17 2017-04-26 花王株式会社 スルフィド化合物の臭いの抑制剤の評価又は選択方法
JP6371336B2 (ja) 2015-06-17 2018-08-08 花王株式会社 ポリスルフィド化合物の臭いの抑制剤
US20200240978A1 (en) * 2017-08-17 2020-07-30 Komi Hakko Corporation Method for quantifying odors, cells used in same, and method for producing said cells
WO2019110630A1 (en) 2017-12-05 2019-06-13 Chemcom S.A. Olfactory receptor involved in the perception of musk fragrance and the use thereof
CN112143547B (zh) * 2020-09-22 2022-07-15 上海桉欣新能源科技有限公司 一种制冷压缩机用润滑油及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361338B2 (en) * 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
ATE417104T1 (de) * 1999-10-05 2008-12-15 Agensys Inc G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen
US7229960B2 (en) * 2000-11-03 2007-06-12 University Of Vermont And State Agricultural College Methods and compositions for inhibiting GRB7
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20030096299A1 (en) * 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
AU2003202542A1 (en) * 2002-01-07 2003-07-24 Euroscreen S.A. Ligand for g-protein coupled receptor gpr43 and uses thereof

Also Published As

Publication number Publication date
EP1864131A2 (de) 2007-12-12
CA2597255C (en) 2014-05-27
CA2597255A1 (en) 2006-09-14
AU2006222265B2 (en) 2012-07-05
EP1864131B1 (de) 2011-09-28
AU2006222265A1 (en) 2006-09-14
ES2373913T3 (es) 2012-02-10
WO2006094704A2 (en) 2006-09-14
JP5307404B2 (ja) 2013-10-02
JP2008538278A (ja) 2008-10-23
US20090264526A1 (en) 2009-10-22
DK1864131T3 (da) 2011-10-31
US8008023B2 (en) 2011-08-30
WO2006094704A3 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
ATE526585T1 (de) Natürlicher ligand des g-protein-gekoppelten rezeptors rcc356 und verwendungen davon
WO2006113557A3 (en) Gpcr modulators
WO2011069156A3 (en) Compositions and methods for enhancing odorant receptor activity
ATE500250T1 (de) Azetidinverbindungen als orexin-rezeptor- antagonisten
MX2007008017A (es) Polipeptidos que se ligan a br3 y usos de los mismos.
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
ATE485359T1 (de) Verwendung von grenzflächenaktiven, nicht- enzymatischen proteinen für die textilwäsche
DE602007012072D1 (de) Orantagonisten
UY29514A1 (es) Agentes de unión
ATE469895T1 (de) Cgrp-rezeptorantagonisten
WO2006002161A3 (en) Modulators of odorant receptors
NO20075580L (no) Silylert polymer avledet fra butadien og losningsmiddelresistent, trykksensitiv limsammensetning som inneholder denne
CY1110579T1 (el) Η λειτουργια ενος υποδοχεα απτοσφαιρινης-αιμοσφαιρινης και οι χρησεις αυτου
EA200702193A1 (ru) Гликозилирование белков
WO2007011907A3 (en) Alpha-synuclein antibodies and methods related thereto
ATE473744T1 (de) Modifizierte pyrimidin-glucocorticoid-rezeptor- modulatoren
EA200901646A1 (ru) Ингибиторы рецепторных тирозинкиназ и их применение
DK2064348T3 (da) Profilering af receptorfamilie
BRPI0609191B8 (pt) métodos e compostos moduladores de receptor de androgênio
MX2007015931A (es) Receptores de sabor dulce-umami y umami-dulce humanos quimericos.
ATE309543T1 (de) Natürlicher ligand von gpcr chemr23 und dessen verwendung
DE602006012694D1 (de) Benzimidazolthiophenverbindungen als plk-modulatoren
ATE474834T1 (de) Als agonisten des gpr38-rezeptors geeignete biarylverbindungen
NO20074277L (no) Kinnolinforbindelser og anvendelse derav som lever X reseptor modulatorer
ATE519498T1 (de) Kombination aus somatostatin-analoga unterschiedlicher selektivität für humane somatostatin-rezeptor-subtypen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1864131

Country of ref document: EP